• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Drug-Coated Balloon for In-Stent Restenosis: First Experience

  • in Cardiovascular · ESC 2005
  • — 12 Sep, 2005
Drug-Coated Balloon for In-Stent Restenosis: First Experience
AudioMedica News
Drug-Coated Balloon for In-Stent Restenosis: First Experience
Drug-Coated Balloon for In-Stent Restenosis: First Experience
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-59"/>
Bruno Scheller
Bruno Scheller

Bruno Scheller, Universitatsklinikum des Saarlandes, Homburg Saar
A future option for treating in-stent restenosis is the idea of coating a balloon with an anti-proliferative drug and inflating it inside the newly-occluded stent. At the ESC Congress, Bruno Scheller from the University of Saarland presented the first study of such a device in humans. He told Audio Medica about it.
[audio:https://www.audiomedica.com/podcasting/18.Bruno_Scheller-Drug-Coated_Balloon_for_In-Stent_Restenosis.mp3]

Click here for all the interviews from ESC 2005

You may also like...

  • Human Growth Hormone: Responses in Severe Heart Failure Human Growth Hormone: Responses in Severe Heart Failure 17 Nov, 2005
  • Is There A Link Between Periodontitis And Heart Disease? Is There A Link Between Periodontitis And Heart Disease? 5 Sep, 2007
  • American College of Cardiology, Orlando American College of Cardiology, Orlando 28 Mar, 2009
  • Could “Polypill” Massively Reduce Heart, Stroke Risks In Healthy People? Could “Polypill” Massively Reduce Heart, Stroke Risks In Healthy People? 31 Mar, 2009

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Endeavor: Alternative Drug-Eluting Stent?
  • Next story RITA-3 Study Five Year Results: Aggressive Management of Acute Coronary Syndrome Now looks Even Better
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Can Initial Radiotherapy Improve Survival with…
    • Childhood Obesity—Whose Business Is It?
  • Home
  • Cardiovascular
  • Drug-Coated Balloon for In-Stent Restenosis: First Experience

© COPYRIGHT 2020 AUDIOMEDICA.COM.